These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 31526875)

  • 1. Efficacy and safety of the first-in-class imidazoline-2 receptor ligand CR4056 in pain from knee osteoarthritis and disease phenotypes: a randomized, double-blind, placebo-controlled phase 2 trial.
    Rovati LC; Brambilla N; Blicharski T; Connell J; Vitalini C; Bonazzi A; Giacovelli G; Girolami F; D'Amato M
    Osteoarthritis Cartilage; 2020 Jan; 28(1):22-30. PubMed ID: 31526875
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of Tanezumab on Joint Pain, Physical Function, and Patient Global Assessment of Osteoarthritis Among Patients With Osteoarthritis of the Hip or Knee: A Randomized Clinical Trial.
    Schnitzer TJ; Easton R; Pang S; Levinson DJ; Pixton G; Viktrup L; Davignon I; Brown MT; West CR; Verburg KM
    JAMA; 2019 Jul; 322(1):37-48. PubMed ID: 31265100
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lorecivivint, a Novel Intraarticular CDC-like Kinase 2 and Dual-Specificity Tyrosine Phosphorylation-Regulated Kinase 1A Inhibitor and Wnt Pathway Modulator for the Treatment of Knee Osteoarthritis: A Phase II Randomized Trial.
    Yazici Y; McAlindon TE; Gibofsky A; Lane NE; Clauw D; Jones M; Bergfeld J; Swearingen CJ; DiFrancesco A; Simsek I; Tambiah J; Hochberg MC
    Arthritis Rheumatol; 2020 Oct; 72(10):1694-1706. PubMed ID: 32432388
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy and safety of intra-articular injection of tropomyosin receptor kinase A inhibitor in painful knee osteoarthritis: a randomized, double-blind and placebo-controlled study.
    Krupka E; Jiang GL; Jan C
    Osteoarthritis Cartilage; 2019 Nov; 27(11):1599-1607. PubMed ID: 31351965
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combined Treatment With Chondroitin Sulfate and Glucosamine Sulfate Shows No Superiority Over Placebo for Reduction of Joint Pain and Functional Impairment in Patients With Knee Osteoarthritis: A Six-Month Multicenter, Randomized, Double-Blind, Placebo-Controlled Clinical Trial.
    Roman-Blas JA; Castañeda S; Sánchez-Pernaute O; Largo R; Herrero-Beaumont G;
    Arthritis Rheumatol; 2017 Jan; 69(1):77-85. PubMed ID: 27477804
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A 2-week, multicenter, randomized, double-blind, placebo-controlled, dose-ranging, phase III trial comparing the efficacy of oxymorphone extended release and placebo in adults with pain associated with osteoarthritis of the hip or knee.
    Kivitz A; Ma C; Ahdieh H; Galer BS
    Clin Ther; 2006 Mar; 28(3):352-64. PubMed ID: 16750450
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Efficacy, Tolerability, and Joint Safety of Fasinumab in Osteoarthritis Pain: A Phase IIb/III Double-Blind, Placebo-Controlled, Randomized Clinical Trial.
    Dakin P; DiMartino SJ; Gao H; Maloney J; Kivitz AJ; Schnitzer TJ; Stahl N; Yancopoulos GD; Geba GP
    Arthritis Rheumatol; 2019 Nov; 71(11):1824-1834. PubMed ID: 31207169
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fasinumab (REGN475), an antibody against nerve growth factor for the treatment of pain: results from a double-blind, placebo-controlled exploratory study in osteoarthritis of the knee.
    Tiseo PJ; Kivitz AJ; Ervin JE; Ren H; Mellis SJ
    Pain; 2014 Jul; 155(7):1245-1252. PubMed ID: 24686255
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pain reduction with oral methotrexate in knee osteoarthritis, a pragmatic phase iii trial of treatment effectiveness (PROMOTE): study protocol for a randomized controlled trial.
    Kingsbury SR; Tharmanathan P; Arden NK; Batley M; Birrell F; Cocks K; Doherty M; Edwards CJ; Garrood T; Grainger AJ; Green M; Hewitt C; Hughes R; Moots R; O'Neill TW; Roddy E; Scott DL; Watt FE; Torgerson DJ; Conaghan PG
    Trials; 2015 Mar; 16():77. PubMed ID: 25872649
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CR4056, a powerful analgesic imidazoline-2 receptor ligand, inhibits the inflammation-induced PKCε phosphorylation and membrane translocation in sensory neurons.
    Vellani V; Sabatini C; Milia C; Caselli G; Lanza M; Letari O; Rovati LC; Giacomoni C
    Br J Pharmacol; 2020 Jan; 177(1):48-64. PubMed ID: 31454418
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A randomized double-blind placebo-controlled trial to investigate the effectiveness and safety of a novel green-lipped mussel extract -BioLex® -for managing pain in moderate to severe osteoarthritis of the hip and knee.
    Stebbings S; Gray A; Schneiders AG; Sansom A
    BMC Complement Altern Med; 2017 Aug; 17(1):416. PubMed ID: 28830491
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Modulation of imidazoline I2 binding sites by CR4056 relieves postoperative hyperalgesia in male and female rats.
    Lanza M; Ferrari F; Menghetti I; Tremolada D; Caselli G
    Br J Pharmacol; 2014 Aug; 171(15):3693-701. PubMed ID: 24758515
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bio-optimized Curcuma longa extract is efficient on knee osteoarthritis pain: a double-blind multicenter randomized placebo controlled three-arm study.
    Henrotin Y; Malaise M; Wittoek R; de Vlam K; Brasseur JP; Luyten FP; Jiangang Q; Van den Berghe M; Uhoda R; Bentin J; De Vroey T; Erpicum L; Donneau AF; Dierckxsens Y
    Arthritis Res Ther; 2019 Jul; 21(1):179. PubMed ID: 31351488
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Single intra-articular injection of lightly cross-linked hyaluronic acid reduces knee pain in symptomatic knee osteoarthritis: a multicenter, double-blind, randomized, placebo-controlled trial.
    Petterson SC; Plancher KD
    Knee Surg Sports Traumatol Arthrosc; 2019 Jun; 27(6):1992-2002. PubMed ID: 30159738
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tropomyosin-related kinase A (TrkA) inhibition for the treatment of painful knee osteoarthritis: results from a randomized controlled phase 2a trial.
    Watt FE; Blauwet MB; Fakhoury A; Jacobs H; Smulders R; Lane NE
    Osteoarthritis Cartilage; 2019 Nov; 27(11):1590-1598. PubMed ID: 31356878
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy and safety of twice daily sustained-release paracetamol formulation for osteoarthritis pain of the knee or hip: a randomized, double-blind, placebo-controlled, twelve-week study.
    Reed K; Collaku A; Moreira S
    Curr Med Res Opin; 2018 Apr; 34(4):689-699. PubMed ID: 29239664
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Maintenance of effect of duloxetine in Chinese patients with pain due to osteoarthritis: 13-week open-label extension data.
    Wang G; Bi L; Li X; Li Z; Zhao D; Chen J; He D; Wang CN; Wu T; Dueñas H; Skljarevski V; Yue L
    BMC Musculoskelet Disord; 2019 Apr; 20(1):174. PubMed ID: 31010413
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The efficacy and safety of a fixed-dose combination of apocynin and paeonol, APPA, in symptomatic knee OA: A double-blind, randomized, placebo-controlled, clinical trial.
    Bihlet AR; Byrjalsen I; Andersen JR; Reynolds A; Larkins N; Alexandersen P; Rovsing H; Moots R; Conaghan PG
    Osteoarthritis Cartilage; 2024 Jul; 32(7):952-962. PubMed ID: 38697511
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy and safety of low-dose submicron diclofenac for the treatment of osteoarthritis pain: a 12 week, phase 3 study.
    Gibofsky A; Hochberg MC; Jaros MJ; Young CL
    Curr Med Res Opin; 2014 Sep; 30(9):1883-93. PubMed ID: 25050589
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy and safety of E-OA-07 in moderate to severe symptoms of osteoarthritis: a double-blind randomized placebo-controlled study.
    Kulkarni MP; Shakeel A; Shinde BS; Rosenbloom RA
    Am J Ther; 2011; 18(2):170-7. PubMed ID: 21317618
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.